HMGCR and Familial prostate cancer: Notably, although Orho‐Melander et al. found no significant associations with the identified SNPs in the genetic scores for HDL‐C, LDL‐C, or TGs, they found a significant increase in the odds of prostate cancer for each copy of HMGCR rs12916 allele, which mimics the effect of statins (OR: 1.09 [95% CI: 1.01–1.18] per LDL‐C‐lowering T‐allele).